These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Priority systems in the allocation of organs for transplant: should we reward those who have previously agreed to donate? Chandler JA Health Law J; 2005; 13():99-138. PubMed ID: 17044324 [No Abstract] [Full Text] [Related]
26. Matchmaker, matchmaker, make me a match. Lucey MR Transplantation; 2006 Feb; 81(4):503-4. PubMed ID: 16495792 [No Abstract] [Full Text] [Related]
27. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Hayashi PH; Trotter JF; Forman L; Kugelmas M; Steinberg T; Russ P; Wachs M; Bak T; Kam I; Everson GT Liver Transpl; 2004 Jan; 10(1):42-8. PubMed ID: 14755776 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131 [TBL] [Abstract][Full Text] [Related]
30. Liver graft allocation for hepatocellular carcinoma patients: is a forced ablate-and-wait protocol nationally applicable? Bazerbachi F; Aby E; Lake J Liver Transpl; 2014 May; 20(5):629-30. PubMed ID: 24771550 [No Abstract] [Full Text] [Related]
31. Equalizing MELD Scores Over Broad Geographies Is Not the Most Efficacious Way to Allocate a Scarce Resource in a Value-based Environment. Reed A; Chapman WC; Knechtle S; Chavin K; Gilroy R; Klintmalm GB Ann Surg; 2015 Aug; 262(2):220-3. PubMed ID: 26164428 [No Abstract] [Full Text] [Related]
32. Pictorial essay. Hepatocellular carcinoma: imaging and imaging-guided intervention. Lee KH; O'Malley ME; Kachura JR; Haider M; Hanbidge A AJR Am J Roentgenol; 2003 Apr; 180(4):1015-22. PubMed ID: 12646447 [No Abstract] [Full Text] [Related]
33. Transplantation for hepatocellular carcinoma: more haste, less speed? Yang T; Lau WY; Huang B; Schwartz M; Shen F Hepatology; 2015 Oct; 62(4):1327-8. PubMed ID: 25820796 [No Abstract] [Full Text] [Related]
34. [Liver transplantation for hepatocellular carcinoma]. Decaens T; Hurtova M; Duvoux C Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):61-9. PubMed ID: 19108968 [No Abstract] [Full Text] [Related]
35. Liver transplantation for hepatocellular carcinoma. Hemming AW; Nelson DR; Reed AI Minerva Chir; 2002 Oct; 57(5):575-85. PubMed ID: 12370659 [TBL] [Abstract][Full Text] [Related]
37. Selecting patients with hepatocellular carcinoma for liver transplantation: who should receive priority? Bazerbachi F; Aby E; Lake JR Liver Transpl; 2013 Dec; 19(12):1289-91. PubMed ID: 24214873 [No Abstract] [Full Text] [Related]
38. Liver transplantation in the MELD era: a single-center experience. Sachdev M; Hernandez JL; Sharma P; Douglas DD; Byrne T; Harrison ME; Mulligan D; Moss A; Reddy K; Vargas HE; Rakela J; Balan V Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573 [TBL] [Abstract][Full Text] [Related]
39. Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Adler M; De Pauw F; Vereerstraeten P; Fancello A; Lerut J; Starkel P; Van Vlierberghe H; Troisi R; Donckier V; Detry O; Delwaide J; Michielsen P; Chapelle T; Pirenne J; Nevens F Liver Transpl; 2008 Apr; 14(4):526-33. PubMed ID: 18383082 [TBL] [Abstract][Full Text] [Related]
40. Waiting time and transplantation for hepatocellular cancer: a balance between Tempus Fugit and Carpe Diem. Lai Q; Lerut J; Hepatology; 2015 Apr; 61(4):1438-9. PubMed ID: 25209193 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]